MARKETSJim Cramer Explains How Pfizer's Hospira Acquisition Helps Pharmaceutical GiantBy Andrew MeolaFeb 5, 2015 1:02 PM EST
MARKETSDana Holding (DAN) Stock Higher Today Ahead of Joining S&P MidCap 400By Kurumi FukushimaJan 21, 2015 12:17 PM EST
MARKETSTrade-Ideas: Cubist Pharmaceuticals (CBST) Is Today's New Lifetime High StockBy Jamie HodgeJan 14, 2015 9:46 AM EST
MERGERS AND ACQUISITIONSOrphan Drug Company NPS Pharmaceuticals May Find Few BuyersBy Laura CooperJan 6, 2015 5:39 PM EST
STOCKSCempra Oral Antibiotic Effective Against Hard-to-Treat PneumoniaBy Adam FeuersteinJan 4, 2015 10:32 PM EST
INVESTINGJim Cramer on the Markets: Some Stocks You Just Can't IgnoreBy Jim CramerDec 23, 2014 10:03 AM EST
MARKETSCubist Pharmaceuticals (CBST): Today's Pre-Market Leader StockBy David M. AferiatDec 22, 2014 8:06 AM EST
MARKETSCubist Pharmaceuticals (CBST) Showing Signs Of Being A Momo Momentum StockBy Daniel MirkinDec 19, 2014 9:45 AM EST
STOCKS2015 Biotech Drug/Stock Outlook: Here's What You Need to KnowBy Adam FeuersteinDec 17, 2014 9:20 AM EST
OPINIONHealth Care Stocks: A Year in Review and Predictions for 2015By Richard SaintvilusDec 10, 2014 11:38 AM EST
INVESTINGMerck May Have Paid $2B-$3B Too Much For Cubist, Analyst SaysBy The Fly StaffDec 9, 2014 1:19 PM EST
MARKETSCubist Pharmaceutical (CBST) Stock Declines Today Following Patent RejectionBy Tony OwusuDec 9, 2014 11:51 AM EST
INVESTINGJim Cramer on the Stock Market: Thoughts on Merck's Deal for CubistBy Jim CramerDec 9, 2014 10:59 AM EST
MARKETSCubist Pharmaceuticals (CBST) Is Today's Perilous Reversal StockBy Scott OlsonDec 9, 2014 9:47 AM EST
JIM CRAMERJim Cramer's 'Mad Money' Recap: Why You Should Buy Disney, Starbucks, Nike NowBy Bret KenwellDec 8, 2014 8:34 PM EST
MARKETSStocks Are Dragged Lower as Oil Prices Plunge to 5-Year LowBy Keris Alison LahiffDec 8, 2014 4:24 PM EST
MARKETSStocks Recover From Session Lows Though Oil Prices Continue to HurtBy Keris Alison LahiffDec 8, 2014 3:30 PM EST
MARKETSWhy Jim Cramer Likes Merck's Acquisition of Cubist Pharmaceuticals (CBST)By Andrew MeolaDec 8, 2014 3:17 PM EST
OPINIONMerck Seeks Growth Injection, Picks Off Antibiotic Maker CubistBy Richard SaintvilusDec 8, 2014 2:56 PM EST
MERGERS AND ACQUISITIONSMerck to Buy Cubist Pharmaceuticals in $9.5 Billion DealBy Laura CooperDec 8, 2014 11:36 AM EST
MARKETSStocks Near Flatline as Rally in Pharmaceuticals Overshadows Energy SelloffBy Keris Alison LahiffDec 8, 2014 11:04 AM EST
MARKETSStock Futures Slide as Crude Oil Tumbles Below $65 a BarrelBy Keris Alison LahiffDec 8, 2014 8:54 AM EST
MARKETSCubist Pharmaceuticals (CBST) Stock Skyrockets Today on $8.4 Billion Merck DealBy Tedd CohenDec 8, 2014 7:57 AM EST
